Merck & Co. Inc. buy Citigroup Inc.
Start price
28.01.25
/
50%
€93.60
Target price
28.01.26
€119.86
Performance (%)
-8.86%
Price
17.12.25
€84.50
Summary
This prediction is currently active. With a performance of -8.86%, the BUY prediction by Citigroup_Inc_ is trending in the wrong direction. A total of €0.81 was paid as dividends for this prediction. This prediction currently runs until 28.01.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Merck & Co. Inc. | 1.198% | 1.198% |
| iShares Core DAX® | -1.212% | 1.925% |
| iShares Nasdaq 100 | -4.714% | -1.810% |
| iShares Nikkei 225® | -2.976% | -2.660% |
| iShares S&P 500 | -2.744% | -0.448% |
Comments by Citigroup_Inc_ for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) had its price target lowered by analysts at Citigroup Inc. from $130.00 to $125.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€86.00
05.02.25
05.02.25
€110.32
05.02.26
05.02.26
-0.80%
17.12.25
17.12.25
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€96.70
25.10.24
25.10.24
€120.32
25.10.25
25.10.25
-21.92%
26.10.25
26.10.25